Lyme Disease Diagnosis Study

Novel Diagnostics for Lyme Disease

Protocol Description

This multi-center study creates a repository of biosamples from patients undergoing evaluation for Lyme disease in the emergency department to aid in the development of novel Lyme disease diagnostics. Researchers believe that new laboratory methods looking for biological markers could provide a faster and more accurate way to determine if a person has Lyme disease.

Eligibility Criteria

Patients of both genders, ages 1 through 20, who present in the Emergency Department of UPMC Children’s Hospital of Pittsburgh and are being tested for Lyme disease will be eligible to participate in this study.
Males and Females: Ages 1 through 20 years


In testing for Lyme disease using traditional methods, a blood sample is taken. For this study, an additional blood sample will be taken for the biorepository. Researchers will use these biosamples to determine if Lyme disease can be more accurately identified using the novel diagnostic approaches.
Visits: 1, the visit to the Emergency Department
Duration: Not applicable

Status: Open to Enrollment

Source(s) of Support

Boston Children’s Hospital
Bay Area Lyme Foundation, Portola Valley, California
Department of Defense

Additional Information

Lyme Disease
Emergency Medicine Research

Primary Investigator

Desiree Noel Wagner Neville, MD

Contact Information

For more information about the study or enrollment, please contact:
Research Coordinator